Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03383432
Other study ID # IUD-TAUSSA
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2019
Est. completion date August 1, 2020

Study information

Verified date February 2021
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The intrauterine device is a safe, reliable and long-acting reversible contraceptive method. Instrumentation of lower genital mucosa during intrauterine device application provokes pain because it is highly sensitive to touch. Fear of pain associated with intrauterine device insertion is considered a barrier to use this contraception method. The classic insertion instructions recommend performing bimanual examination and uterine sounding prior to intrauterine device insertion in order to confirm proper determination of uterine size and position. The pain during intrauterine device insertion could be due to cervical grasping by the tenaculum, traction on the cervical canal, stretching of the internal os by the uterine sound or the intrauterine device inserter, and lastly by irritation of the endometrial lining by the intrauterine device. Many studies investigated the use of various analgesics in different doses and routes of administration and found out that it has a significant impact on relieving of associated pain Some technical modifications have been emerged in trial to decrease pain during intrauterine device insertion. One of them is trans-abdominal ultrasound guided intrauterine device insertion which the participant with a full bladder is subjected to intrauterine device insertion under ultrasonographic guide without using tenaculum. This method effectively decreased the pain and time of intrauterine device insertion. A recent method named "Uterine Sounding Sparing Approach" has been reported very recently in literature by Ali et al., 2017. In this method; the sonographer performs T transvaginal ultrasound to evaluate the uterine position and the endometrial length in the sagittal view of the uterus. The intrauterine device was inserted directly into the uterine cavity without using uterine sounding. In spite of less pain reported by trans-abdominal ultrasound guided intrauterine device insertion (no vulsellum was used), this methods also have some drawbacks, firstly; the full bladder may displace the cervix upward making the intrauterine device application not quite easy and secondly; this method needs two investigators which may distress the women who wondering about this. These two drawbacks may decrease patient's and physician's satisfaction. The uterine sounding sparing approach lacks these two drawbacks which make it more satisfying. From above evidence, there is a strong need to compare the satisfaction rate between the two mentioned approaches in trial to answer this question. Up to our knowledge; no randomized trial has been conducted or registered to compare the satisfaction rate between two above approaches.


Recruitment information / eligibility

Status Completed
Enrollment 88
Est. completion date August 1, 2020
Est. primary completion date June 1, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 49 Years
Eligibility Inclusion Criteria: 1. Women aged 18-49 years 2. Nonpregnant 3. Women did not receive any analgesics or misoprostol in the 24 hours prior to insertion. Exclusion Criteria: 1. Women with any uterine abnormalities such as congenital anomalies, endometrial lesions, fibroids 2. Allergy to Copper.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Intrauterine device
Copper T 380 A
Radiation:
Ultrasound
Transabdominal ultrasound
Procedure:
uterine sounding sparing technique
we will insert intrauterine device without using the uterine sound and we will replace this step by ultrasound before insertion

Locations

Country Name City State
Egypt Women Health Hospital - Assiut university Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Level of satisfaction of patients in both groups (satisfaction score) Measured by visual analogue like scale from 0 to 10 5 minutes after intrauterine device insertion
Secondary Level of reported pain (visual analogue scale ) 5 minutes after intrauterine device insertion
See also
  Status Clinical Trial Phase
Completed NCT03686085 - Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women. Phase 3
Recruiting NCT05550064 - Structured Contraceptive Counseling During Pregnancy N/A
Recruiting NCT06179095 - The Effect of Virtual Reality on Anxiety During Intrauterine Device Insertion N/A
Completed NCT03600064 - Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal N/A
Completed NCT05556421 - Can Uterocervical Angle Predict the Displacement of Copper Intrauterine Devices (T-Cu 380A)
Completed NCT04045548 - Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Previous Vaginal Delivery Phase 4
Completed NCT03870711 - 10% Lidocaine Spray for Intrauterine Device Insertion Phase 4
Completed NCT02898831 - Cold Compress for Pain Associated With Intrauterine Device Insertion N/A